Exposure and Dosimetry Considerations for Adverse Outcome Pathways
John Wambaugh
0000-0002-4024-534X
10.23645/epacomptox.5078440.v1
https://epa.figshare.com/articles/presentation/Exposure_and_Dosimetry_Considerations_for_Adverse_Outcome_Pathways/5078440
Presented at the Application of New Methods in Risk Science in Regulatory Decision-Making Regarding
Chemical Substances
2017-06-30 13:51:46
Dosimetry
Exposure
High Throughput Toxicokinetics (HTTK)
CompTox
Toxicology